Remedent
REMI · OTC
$0.0008+$0.0008 (+0.00%)TodayMarket closed ·
No price history for this range.
Key indicators
REMI profitability and balance sheet ratios
EPS $0.0047 in Dec 2020, against -$0.0074 a year earlier.
| Period | EPS |
|---|---|
| Mar 2019 | $0.1276 |
| Jun 2019 | -$0.0096 |
| Sep 2019 | -$0.008 |
| Dec 2019 | -$0.0074 |
| Mar 2020 | -$0.018 |
| Jun 2020 | $0.0001 |
| Sep 2020 | $0.0002 |
| Dec 2020 | $0.0047 |
Income statement
No financial statements are reported for Remedent.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Jun 2020 | Sep 2020 | Dec 2020 |
|---|---|---|---|
| Total assets | $7.5M | $7.5M | $7.6M |
| Total liabilities | $2.9M | $3.0M | $3.0M |
| Shareholder equity | $4.5M | $4.5M | $4.6M |
| Cash and short-term investments | $0.1M | $0.1M | $0.1M |
| Total debt | $0.0M | $0.0M | $0.0M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.